ARTICLE | Company News
Illumina, IBM deal
January 13, 2017 7:49 PM UTC
IBM and Illumina will use the cloud-based platform IBM Watson for Genomics to compare variant genetic data produced by TruSight Tumor 170 to published medical literature. TruSight Tumor 170 is a resea...